These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22250750)

  • 1. Association of chemotherapeutic drugs with dendrimer nanocarriers: an assessment of the merits of covalent conjugation compared to noncovalent encapsulation.
    Kaminskas LM; McLeod VM; Porter CJ; Boyd BJ
    Mol Pharm; 2012 Mar; 9(3):355-73. PubMed ID: 22250750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progress of polyamidoamine dendrimer in targeting drug delivery system].
    Ding RM; He H; Li J
    Yao Xue Xue Bao; 2011 May; 46(5):493-501. PubMed ID: 21800534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.
    Bugno J; Hsu HJ; Hong S
    J Drug Target; 2015; 23(7-8):642-50. PubMed ID: 26453160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs.
    Dubey SK; Salunkhe S; Agrawal M; Kali M; Singhvi G; Tiwari S; Saraf S; Saraf S; Alexander A
    Curr Drug Targets; 2020; 21(6):528-540. PubMed ID: 31670619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery.
    Sharma AK; Gothwal A; Kesharwani P; Alsaab H; Iyer AK; Gupta U
    Drug Discov Today; 2017 Feb; 22(2):314-326. PubMed ID: 27671487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendrimers in anticancer drug delivery: mechanism of interaction of drug and dendrimers.
    Singh J; Jain K; Mehra NK; Jain NK
    Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1626-34. PubMed ID: 26747336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-administration of a charge-conversional dendrimer enhances antitumor efficacy of conventional chemotherapy.
    Cao J; Wang C; Guo L; Xiao Z; Liu K; Yan H
    Eur J Pharm Biopharm; 2018 Jun; 127():371-377. PubMed ID: 29499301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of Dendrimer-based Nanoparticles in Cancer Therapy.
    Castro RI; Forero-Doria O; Guzmán L
    An Acad Bras Cienc; 2018 Aug; 90(2 suppl 1):2331-2346. PubMed ID: 30066746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics.
    Gupta L; Sharma AK; Gothwal A; Khan MS; Khinchi MP; Qayum A; Singh SK; Gupta U
    Int J Pharm; 2017 Aug; 528(1-2):88-99. PubMed ID: 28533175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress in dendrimer-based nanocarriers.
    Bai S; Thomas C; Rawat A; Ahsan F
    Crit Rev Ther Drug Carrier Syst; 2006; 23(6):437-95. PubMed ID: 17425500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
    Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
    Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendrimers as drug carriers: applications in different routes of drug administration.
    Cheng Y; Xu Z; Ma M; Xu T
    J Pharm Sci; 2008 Jan; 97(1):123-43. PubMed ID: 17721949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of dendrimer-drug complexation in the enhancement of drug solubility and bioavailability.
    Jain NK; Gupta U
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1035-52. PubMed ID: 18680439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview.
    Mignani S; El Kazzouli S; Bousmina M; Majoral JP
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1316-30. PubMed ID: 23415951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendrimers for enhanced drug solubilization.
    Svenson S; Chauhan AS
    Nanomedicine (Lond); 2008 Oct; 3(5):679-702. PubMed ID: 18817470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications.
    Kalomiraki M; Thermos K; Chaniotakis NA
    Int J Nanomedicine; 2016; 11():1-12. PubMed ID: 26730187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimer-based nanoparticles for cancer therapy.
    Baker JR
    Hematology Am Soc Hematol Educ Program; 2009; ():708-19. PubMed ID: 20008257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
    Ruiz ME; Gantner ME; Talevi A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.